Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...
At eight years old, I had my third open-heart surgery — this time, to “tune up” my Fontan and implant my first pacemaker.
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...
Good morning. Welcome to today's conference call to discuss Kimberly-Clark's acquisition of Kenvue. [Operator Instructions]. With that, I would now like to turn the call over to Chris Jakubik, ...
Cost of service revenue was $0.9 million for the three months ended September 30 ... maintain or improve functional class, delay disease progression and improve quality of life. About Pulmonary ...
Royalty revenue increased to $1.5 million in the third quarter of 2025 compared to $0.9 million ... a tissue-based comprehensive genomic profiling test to identify and enroll patients whose tumors are ...
Cells convert mechanical forces into signals that influence physiological processes, such as exercise strengthening bones. A ...
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at ...
With the acquisition, Kimberly-Clark gains popular brands, including Neutrogena, Aveeno, Listerine, Benadryl, Band-Aid, and ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Shareholders of Kimberly-Clark<a class="excerpt-read- ...
Precision Medicine Group (Precision), a leading provider of next-generation drug development, CRO and commercialization services, today announced the launch of Institute@Precision, an expert community ...